black tie international magazine
Home
 
Translate
 
Celebrity Philanthropy News
 
Society News
 
Save the Date Directory
 
Black Tie  TV
 
Features
Black Tie China
 
Black Tie France
 
Black Tie Israel
 
Black Tie Philippines
 
Nightlife With
Rose Billings
 
Publisher
Gerard Mc Keon
 
Editor-in-Chief
Joyce Brooks
 
Follow us on 
Twitter   Facebook   Google+   Pinterest
 
 
 
Society News
 
New York Society
Palm Beach Society
International Society
Hampton Society
Las Vegas Society
West Coast Society
U.S. Society
 
Save The Date
Save the Date Directory
 
Listing Non-Profit Events
 
Philanthropy News
Featured Foundations
Philanthropy  Giving
 
Entrepreneurial & Philanthropy Awards
 
Featured
Event Resources
Event Resource Directory
Event Talent Directory
 
Black Tie
Recommended
Lifestyle Selection
Antiques
Art
Beauty
Blockchain Investment
Cars
Couture Fashion
Crowdfunding
Fine Wines
Friends of Black Tie
Gen Z Success Mentoring
 Health & Wellness
Impact Investment
Interior Design
Investigative Services
Jewelry
Kids on Location
Legal Services
Luxury Yachts
Pet Services
Private Air
 Real Estate
Recommended Reading
Restaurant Reviews
Single Friendly Events
Social Announcements
Sustainable Investment
Technology
Theater/Arts
Travel
Wealth Management
 
 
Share this Page
 
Promote Your Business or Foundation:
Advertising
Co-Hosting Events
 
Featured Foundations
Listing Non-Profit Events
 
Promote your Services
Feature your Talent
 
Friends of
Black Tie
Add your e-mail
for invitations to  our
exclusive
Friends of Black Tie Events

 
Friends of Black Tie
 
 
Black Tie Classic
Current Issue
Diana Issue
Jacqueline Kennedy
Back Issues
More Back Issues
Black Tie TV
Online Store 1
 
 
 

 

web
analytics
 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Society News  Pages 1  2  3

E- mail this page to your friends

Black Tie International Hosts
Dr. Michel Sadelain


 
 
THE IMPACT OF GENE THERAPY ON LYMPHOMA, LEUKEMIA AND PROSTATE CANCER

Topic of Recent Alliance for Cancer Gene Therapy Presentation

 

Dr. Michel Sadelain, founding director of the Center for Cell Engineering and head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan-Kettering Cancer Center, chats with ACGT co-founder and event chair, Barbara Netter of Greenwich, at a recent educational seminar on advances in treating cancer, which ACGT sponsored.

Dr. Michel Sadelain, founding director of the Center for Cell Engineering and head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan-Kettering Cancer Center, chats with ACGT co-founder and event chair, Barbara Netter of Greenwich, at a recent educational seminar on advances in treating cancer, which ACGT sponsored.

 

 
 
 

A five-time All American triathlete, a judge, a doctor, a Rabbi, a philanthropist, and business leaders are not typically the faces of cancer one thinks of.  However, cancer is indiscriminate and affects people of all ages, professions, and walks of life.  These are among the people who filled the room recently at the Bruce Museum in Greenwich, Conn., to hear renowned cancer researcher Dr. Michel Sadelain of Memorial Sloan-Kettering Cancer Center speak about new advances in treating lymphoma, leukemia and prostate cancer.  Members of the audience, many whose lives have been touched by cancer, either personally or through loved ones, came to hear firsthand from a leading scientist at the forefront of working toward new treatments for cancer. The presentation was sponsored by the Alliance for Cancer Gene Therapy (ACGT), founded by Greenwich residents Barbara and Edward Netter.
 
The presenter, Dr. Michel Sadelain, is founding director of the Center for Cell Engineering and head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan-Kettering Cancer Center. Dr. Sadelain is also the recipient of a 2004 ACGT Investigator Grant for Gene Therapy for his work with Lymphoma and Leukemia. His research focuses on novel approaches to enhance T cell stimulation and function. T cell engineering is a promising approach for establishing potent and durable immunity against cancer. Dr. Sadelain’s research is currently in clinical trials and uses engineered T cells to create an immune response against cancer cells.  Seven other major medical centers are also initiating clinical trials on similar work in the next year.  
 
The challenge has been to modify the patient’s T cells to persist and function in the recipient.  Drug therapy only lasts for a certain amount of time after it is put into the body, and radiation and chemotherapy damage good cells as well as the bad.  The goal of Dr. Sadelain’s research is to create genetically engineered T cells that specifically recognize the tumor and function as long as there is residual tumor to eradicate.             
 
Barbara Netter, event chairman, noted, “Dr. Sadelain’s research is exciting because, he’s isn’t just looking for a treatment, but a process of engineering cells that works in the body, wiping out cancer cells, leaving the rest of the body healthy.“                                        
 
Dr. Sadelain explained the process to the audience by giving the “nuts and bolts” of the cell engineering process, explaining how the engineered cells enhance the immune system and specifically target cancer cells.  The T cells are taken directly from the patient’s blood.  The T cells are genetically engineered to extend their survival in the body and overcome the resistance opposed by the tumor cells and surrounding cells that shield the tumor. Dr. Sadelain and his team insert a receptor into the gene that specifically targets the cancer cells.  
 
Memorial Sloan-Kettering is one of a handful of laboratories in the U.S. that have the capability to manufacture T cells with specific receptors.  The difference between Dr. Sadelain’s work with gene therapy and other conventional treatments is that he works with live cells that have the potential to amplify and persist, unlike drugs, which require repeated and sometimes lifelong administration.  The goal is to have the T cells live on and continue to fight cancer cells in the body.
 
In experiments with lab mice, some have had a 60-to-80 percent reduction in cancer in their body after being treated with engineered T cells.
 
Clinical studies have begun at Memorial Sloan-Kettering in patients with chronic lymphocytic leukemia and will soon extend to those with acute leukemia and prostate cancer.  Currently, there are several human clinical trials on treating lymphoma and leukemia, based on Dr. Sadelain’s research with gene therapy, and can be found through ACGT’s website at www.acgtfoundation.org <http://www.acgtfoundation.org>.
 
Gene therapy or immune engineering is an emerging science. Dr. Sadelain’s wide range and deep understanding of the subject matter left the audience with a sense of where cancer research is headed… a more targeted and less invasive approach to cancer treatment.  After Dr. Sadelain’s presentation, many in the audience crowded around him to talk to him personally about his work and its implications for treating cancer.  And for them, the future looked a lot brighter.
 
Dr. Michel Sadelain is the founding director of the Center for Cell Engineering and Head of the Gene Transfer and Gene Expression Laboratory at Memorial Sloan-Kettering Cancer Center in New York, where he also currently holds the Stephen and Barbara Friedman Chair. Dr. Sadelain received his medical degree from the University of Paris and his PhD from the University of Alberta. After his residency at the Centre Hospitalier Universitaire Saint-Antoine in Paris, he completed his fellowship at the Massachusetts Institute of Technology, before joining Memorial Sloan-Kettering Cancer Center. Dr. Sadelain previously served on the Board of Directors of the American Society of Gene Therapy (2004-2007) and continues to serve on the editorial boards of Molecular Therapy, Human Gene Therapy and Gene Therapy. He is a member of the prestigious 17 member ACGT Scientific Advisory Council.

The Alliance for Cancer Gene Therapy (ACGT) supports the extraordinary potential offered by cell and gene-based therapies to accelerate effective and safe treatment of all types of cancer. Founded in 2001 by Greenwich residents Barbara and Edward Netter, it is the only national non-profit organization committed exclusively to cancer gene therapy research and is recipient of the BBB Accredited Charity Seal.  One hundred percent (100%) of all funds raised by ACGT goes directly to support medical research.
 
Since its inception in 2001, ACGT has issued close to $20 million in research grants to 31 ACGT Research Fellows representing such leading research institutions as Harvard Medical School, Johns Hopkins University School of Medicine, Mayo Clinic, St. Jude’s Children’s Hospital, Duke University, The Salk Institute, University of Pennsylvania, Memorial Sloan-Kettering, University of Pittsburgh’s School of Medicine, and the University of Chicago. Identified through a rigorous selection procedure, the scientists and their research projects address lymphoma/leukemia, prostate, breast, lung, brain and ovarian cancer.
 

www.acgtfoundation.org



 
 

 

 

 

To list an upcoming event please contact:
joyce@blacktiemagazine.com

 
 
Back to Society News


 




 

 


Save the Date

 

Ireland Fund

 
 
Brooks USa Polo


 

Search the Site

 

 

Featured Foundations

Waggle
 

Impact Investment

cortez tidal electrical generating project
 

Black Tie China

#chianphilanthropy
 
 

Black Tie Philippines

black tie philippines
 

Nightlife with Rose Billings

debutante Ball
 
 
Gerard Mc Keon
 

Celebrity Philanthropy News

jean shafiroff, paul mc cartney
 
princess margaret of kent
 
hudson river park annual Gala
 
Al Pacino, American Icon Awards
 
clive davis
 
proincess grace awards
 
american hospital of paris foundation
 
french heritage society
 
lupus research alliance
 
un women for peace
 
ben kingsley
 
Friends of Black Tie
 
ceylon tea party
 
ecosoc
 
joyce brooks
 
central park conservatory
 
UN Correspondents Association
 
cardinal dolan
 
palm beach heart ball
 
vienese opera ball
 
lady in red gala
 
sanford stem cell
 
weizmann institute
 
carlos slim
 
israel 65th anniversary
 

Black Tie International Realty

 

Event Resources Directory

event resource directory
 
 


 

 
 
 
 
 
 
 
 
 
 

Copyright 2006 Black Tie Magazine. All Rights Reserved .

Privacy Policy |